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der(7)t(1;7)(q10;p10) G- (left) and R- (right) bandings - top: Courtesy Jean-Luc Lai; middle and bottom: - Courtesy Diane H. 
Norback, Eric B. Johnson, and Sara Morrison-Delap,  UW Cytogenetic Services. 
Clinics and pathology 
Disease 
Myelodysplasic syndromes (MDS) in 60% of cases, 
often evolving towards acute non lymphoblastic  
leukaemia (ANLL); ANLL in 30%, frequently with 
preceeding MDS; these MDS or ANLL are therapy-
related (secondary to toxic exposure) in half cases; 
myeloproliferative diseases (MPD) represent the 
remaining 10% of cases. 
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Phenotype/cell stem origin 
MDS cases: often RAEB±T or RA; ANLL: M4 or 
M1; MPD cases: myelofibrosis. 
Epidemiology 
Represent 3-7% of secondary leukaemias, 0.5% and 
2% of de novo ANLL and MDS respectively; adults 
mostly (median 60 yrs; only a very few children 
cases); male predominance (3M/2F), but secondary 
leukaemias cases are more frequently female cases 
(presence of uncovered environmental genotoxic 
factors in male cases?). 
Prognosis 
Poor prognosis; median survival was reviewed in 
1992 and was found to be of 11 mths; male sex, a 
low haemoglobin level may be adverse prognostic 




Whole-arm translocation of 7p with 1q; most often 
unbalanced (-7, +t(1;7)) --> trisomy for 
1q/monosomy for 7q; may therefore represent an 




Sole anomaly in half; hyperploidy in 1/3 of cases; 
+8 (20%); +21 (10%); +9; additional structural 
abnormalities in 15%. 
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